Search hospitals

>

Washington

>

Seattle

Harborview Medical Center

Claim this profile

Seattle, Washington 98104

Global Leader in Stroke

Global Leader in Lung Cancer

Conducts research for Breast Cancer

Conducts research for Lymphoma

Conducts research for Peroneal Nerve Injury

419 reported clinical trials

24 medical researchers

Photo of Harborview Medical Center in SeattlePhoto of Harborview Medical Center in Seattle

Summary

Harborview Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Stroke, Lung Cancer, Breast Cancer, Lymphoma, Peroneal Nerve Injury and other specialties. Harborview Medical Center is involved with conducting 419 clinical trials across 598 conditions. There are 24 research doctors associated with this hospital, such as Charles Landis, MD, Charles Bernick, Michael Levitt, MD, and Shahin Hakimian, MD.

Area of expertise

1

Stroke

Global Leader

Harborview Medical Center has run 25 trials for Stroke.

2

Lung Cancer

Global Leader

Harborview Medical Center has run 24 trials for Lung Cancer. Some of their research focus areas include:

Stage I
Stage II
Stage III

Top PIs

Clinical Trials running at Harborview Medical Center

Stroke

Breast Cancer

Traumatic Brain Injury

Vascular Dementia

Bladder Cancer

Cognitive Impairment

Prostate Cancer

Hemorrhagic Shock

Bleeding

Nerve Damage

Image of trial facility.

Semaglutide

for Type 2 Diabetes

A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting. The study will randomize subjects with diabetes to either semaglutide or matching placebo. Magnetic resonance images will be primary endpoint measured at baseline and at one year to assess effect of this FDA approved medication. Given the available evidence supporting the neuroprotective effect of this drug class and stroke reduction with semaglutide, and the investigators preliminary data showing that T2D had significantly reduced total number of distal arterial branches in the brain than non-T2D, the investigators expect treatment with semaglutide will be associated with improved intracranial blood flow condition.

Recruiting

2 awards

Phase 4

5 criteria

Image of trial facility.

Endovascular Thrombectomy

for Stroke

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

Recruiting

1 award

N/A

2 criteria

Image of trial facility.

Transcranial Magnetic Stimulation

for Stroke

VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.

Recruiting

1 award

N/A

6 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Harborview Medical Center?

Where is Harborview Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Harborview Medical Center accept?

What awards or recognition has Harborview Medical Center received?